Introduction
The hormone leptin, which is produced by adipocytes to signal the repletion of body energy (fat) stores, acts via the leptin receptor (LepRb) on specialized populations of brain neurons to control food intake, energy expenditure, and other metabolic parameters (1) (2) (3) (4) . The fall in circulating leptin concentrations during negative energy balance increases hunger and initiates an energy-sparing neuroendocrine program characterized by decreased sympathetic nervous system (SNS) tone and diminished activity of the thyroid, reproductive, and growth axes, among others. This response not only tends to replenish body energy stores by increasing feeding relative to energy utilization when food is available, but also preserves remaining energy stores in the face of continued famine, increasing the chances of survival until food becomes available.
The withdrawal of leptin action from LepRb neurons in the hypothalamus mediates most of these orexigenic and energysparing responses to negative energy balance (5) . While brain stem sites contain many LepRb neurons, roles for most populations of brain stem LepRb neurons, including the largest population (located in the periaqueductal gray [PAG] ), remain undefined (6, 7) .
In isolation, the energy-sparing neuroendocrine response to negative energy balance carries a potential risk, however. The reduction of energy stores coupled with decreased SNS tone impairs the ability to respond to acute, potentially life-threatening emergencies that require the robust mobilization of metabolic fuels, such as glucose. Thus, during negative energy balance, meeting acutely elevated metabolic needs requires a system that increases the drive to mobilize glucose beyond that which is required when energy reserves are replete. Furthermore, this system must activate specifically in response to metabolic emergencies without otherwise altering SNS tone and glucose mobilization (otherwise, this would blunt the energy-sparing response to negative energy balance). Indeed, we previously defined a system that augments the counterregulatory response (CRR) to hypoglycemia when energy stores are diminished: hypoglycemia activates cholecystokinin-containing (CCK-containing) neurons in the hindbrain parabrachial nucleus (PBN), which project to the ventromedial hypothalamic nucleus (VMN) (which plays a crucial role in the CRR) (8, 9) . Some PBN CCK neurons contain LepRb; during negative energy balance, the withdrawal of leptin from these PBN LepRb cells augments their response to low glucose, enhancing glucose mobilization during hypoglycemia without altering baseline endocrine function, energy balance, or glucose homeostasis (8) .
We reasoned that other stimuli that signal the need for robust SNS activation and glucose mobilization might similarly engage the PBN→VMN circuit to meet acutely increased metabolic demands when energy stores are low. Because noxious stimuli (such as pain) increase blood glucose and often indicate the need for SNS activation and nutrient mobilization, we sought to understand the potential role for hindbrain LepRb neurons in modulating the response to noxious stimuli in line with the repletion state of body energy stores. We find that LepRb neurons in the PAG (which plays crucial roles in responding to noxious stimuli; refs. 10-13) lie Adipocytes secrete the hormone leptin to signal the sufficiency of energy stores. Reductions in circulating leptin concentrations reflect a negative energy balance, which augments sympathetic nervous system (SNS) activation in response to metabolically demanding emergencies. This process ensures adequate glucose mobilization despite low energy stores. We report that leptin receptor-expressing neurons (LepRb neurons) in the periaqueductal gray (PAG), the largest population of LepRb neurons in the brain stem, mediate this process. Application of noxious stimuli, which often signal the need to mobilize glucose to support an appropriate response, activated PAG LepRb neurons, which project to and activate parabrachial nucleus (PBN) neurons that control SNS activation and glucose mobilization. Furthermore, activating PAG LepRb neurons increased SNS activity and blood glucose concentrations, while ablating LepRb in PAG neurons augmented glucose mobilization in response to noxious stimuli. Thus, decreased leptin action on PAG LepRb neurons augments the autonomic response to noxious stimuli, ensuring sufficient glucose mobilization during periods of acute demand in the face of diminished energy stores.
A leptin-regulated circuit controls glucose mobilization during noxious stimuli 3 Figure 1B) , which express an L10a-GFP fusion protein in LepRb neurons, enabling their detection by αGFP immunohistochemistry ( Figure 1 and Supplemental Figure 1 ; supplemental material available online with this article; https://doi.org/ 10.1172/JCI90147DS1). Indeed, in LepRb L10a-GFP mice, formalin injection into the footpad promoted c-Fos accumulation in 38% of LepRb PBN neurons (562 ± 23 cells, mean ± SEM; n = 5) ( Figure  1 , C and D), similar to the effect of glucoprivation by the injection of 2-deoxyglucose (2DG) (which mimics hypoglycemia at the cellular level) on these cells (568 ± 6 cells, mean ± SEM; n = 3) ( Figure 1 , E and F), suggesting that LepRb PBN neurons might play a role in modulating the response to noxious stimuli, in addition to hypoglycemia, during negative energy balance. Additionally, formalin injection activated approximately 23% of the LepRb neurons (1862 ± 106 cells, mean ± SEM; n = 5) in the neighboring PAG (LepRb PAG neurons) ( Figure 1, G 
Results

Noxious stimuli activate LepRb neurons in the PBN and PAG.
Pain and other noxious stimuli activate the SNS and promote the mobilization of metabolic fuels to support the ability to cope with the stimulus-evoking event. Thus, short-term survival when faced with a noxious stimulus during negative energy balance requires a brain system that can overcome low SNS tone and depleted energy stores to support nutrient mobilization. Indeed, a 12-hour fast enhances the hyperglycemic response to the injection of 5% formalin into the footpad of the hind paw (a common noxious stimulus model; refs. 14-16) ( Figure 1A ).
Since the withdrawal of leptin from leptin-inhibited LepRb neurons in the PBN (LepRb PBN cells) enhances SNS activation and glucose mobilization during hypoglycemia (8) , mitigating the impairment of the CRR that would otherwise occur during negative energy balance, we sought to determine whether the LepRb PBN circuitry might similarly modulate the response to noxious stimuli. We thus examined the potential activation of LepRb PBN cells
Figure 1. Hyperglycemic and c-Fos responses to noxious stimuli. (A)
Ad libitum-fed (n = 10) and overnight-fasted (n = 8) C57BL/6 mice were injected with intra-hind paw formalin (5%, 20 μl), and blood glucose concentrations were measured over the subsequent 3 hours. Data are plotted as mean ± SEM. (B) LepRb eGFP-L10a mice were treated with (C, D, G, H) intra-hind paw formalin (n = 4, veh; n = 5, formalin) as in A or (E, F, I, J) 2DG (n = 5, veh; n = 4, 2DG) (500 mg/kg, i.p.) and perfused under anesthesia. Brains were collected and sectioned; sections were stained for c-Fos (DAB, purple) and GFP (green). Images (C, E, G, I) are representative of 4-5 similar animals for each treatment. Graphs show colocalized cells/total LepRb cells, plotted as percentage, mean ± SEM. *P < 0.05. Scale bars: 100 μm. Data in panel A were analyzed by 2-way repeated-measures ANOVA with Fisher's LSD post hoc test, and data in panels D, F, H, and J were analyzed by 1-tailed t test. Cre mice; at the same time, we injected AAVmap2c-dsRed (which mediates the Cre-inducible expression of a map2c-dsRed fusion protein that identifies the dendritic tree) into the PBN of the same mice ( Figure 2A ). This revealed the projection field of LepRb PAG neurons, which densely innervate the PBN, and demonstrated that many of the synaptic terminals from these cells lie in the PBN region that contains the dendritic tree of LepRb PBN neurons ( Figure 2 , B and C). We also found terminals from LepRb PAG neurons in the dorsomedial nucleus of the hypothalamus (DMH) and dorsomedial thalamus (Supplemental Figure 2), although these were much sparser than those in the PBN.
We employed rabies-mediated monosynaptic retrograde tracing (18) to examine the circuitry of PBN-projecting LepRb PAG cells. In this system, the injection of the AAV-TVA+G helper virus mediates expression of TVA in Cre-containing neurons to permit their infection by a pseudotyped, G-deleted, mCherry-expressing rabies virus (Rabies-ΔG-mCherry). AAV-TVA+G also mediates the Credependent expression of G, enabling the passage of Rabies-ΔG-mCherry one synapse retrograde to the Cre-expressing neuron. We injected AAV-TVA+G into the PAG of Lepr Cre-eYFP mice and then delivered Rabies-ΔG-mCherry into the PBN (Figure 2, D-H) . This not only infected many LepRb PAG cells with Rabies-ΔG-mCherry (consistent with our identification of the PBN as a major projection target of LepRb PAG cells), but also revealed numerous Rabies-ΔG- Cre/eYFP mice were injected with AAV-TVA+G into the PAG; 2 weeks later, defective pseudotyped mCherry-expressing rabies virus (Rabies-ΔG-mCherry) was injected into the PBN. Five days later, mice were perfused and brains were collected and sectioned. Brain sections were stained for GFP (green) and dsRed (red) (E and F). Images are representative of 4 similar cases. H shows an enlarged image of G. Scale bars: 100 μm. IC, inferior colliculus; Aq, cerebral aqueduct.
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tially noxious stimuli that reflect increased metabolic demand, we examined the ventilatory response to hypercapnia in animals expressing hM3Dq in LepRb PAG neurons ( Figure 4F ). CNO administration increased breathing frequency in 3% CO 2 , but not in room air, consistent with augmented SNS drive to respiratory centers. Thus, in addition to increasing SNS outflow to the adrenal gland and elevating blood glucose concentrations, activation of LepRb PAG cells augments the ventilatory response to hypercapnia, consistent with a role for these cells in promoting appropriate autonomic responses when metabolic demand is acutely elevated. Figure 5A ). As we previously showed (8) , the hyperglycemic response to glucoprivation is accentuated and prolonged in LepRb CCK KO mice ( Figure 5B), consistent with the role for LepRb PBN neurons in augmenting the CRR to glucoprivation when leptin action is low. Furthermore, LepRb Cck KO mice demonstrated an exaggerated hyperglycemic response to formalin injection, revealing that decreased leptin action on LepRb CCK neurons augments glucose mobilization in response to noxious stimuli ( Figure 5C ).
Ablation of LepRb from the PAG augments the hyperglycemic and ventilatory responses to noxious stimuli.
Since leptin action in LepRb CCK KO mice is only partially interrupted in the PAG and is also ablated in the EW and PBN (8), we sought to determine the role of PAG leptin action specifically in the response to noxious stimuli. We thus injected AAV-Cre or AAV-mCherry (control) into the PAG of Lepr fl/fl mice, disrupting LepRb specifically in the PAG (LepRb PAG KO mice) to reveal the role of LepRb PAG neurons in leptin action ( Figure 6A and Supplemental Figure 7 ). Food intake, body weight, glucose tolerance, insulin-induced hypoglycemia, and the hyperglycemic response to glucoprivation were not altered in LepRb PAG KO mice ( Figure 6 , B-F), consistent with the notion that LepRb PBN cells (rather than LepRb PAG neurons) augment the CRR to hypoglycemia/glucoprivation when leptin action is decreased.
The hyperglycemic response to formalin injection was significantly enhanced in LepRb PAG KO mice, however, revealing that ent to these cells ( Figure 3A ). This analysis revealed Rabies-ΔG-mCherry-infected cells in the PBN as well as identifying afferents of LepRb PBN →VMN neurons in the PAG and in several other nearby areas ( Figure 3B ). We also observed afferents of LepRb PBN →VMN neurons in more distal regions, including the DR, the paraventricular nucleus of the hypothalamus, the bed nucleus of the stria terminalis, and the central nucleus of the amygdala (CeA) (Supplemental Figure 5 ). In addition to demonstrating the expected infection of many GFP-containing LepRb PBN cells by intra-VMN Rabies-ΔG-mCherry ( Figure 3C ), some (<10%) of the PAG neurons afferent to the LepRb PBN →VMN cells contained GFP ( Figure  3D Figure 4A ). We observed 1663 ± 364 (mean ± SEM; n = 7) PBN hM3Dq-expressing cells and 2853 ± 422 (mean ± SEM; n = 9) PAG hM3Dq-expressing cells in our study. We initially observed that activation of either set of LepRb neurons increased locomotor activity (Supplemental Figure 6) , consistent with increased SNS drive following the activation of these cells. Indeed, CNO administration to mice expressing hMD3q either in LepRb PBN Hypercapnia normally signifies an increase in cellular respiration/metabolic demand that is not appropriately compensated by breathing; the PAG participates in the ventilatory response to hypercapnia (19) (20) (21) (22) . To determine whether LepRb PAG neurons might also participate in other autonomic responses to poten- a constitutive AAV-TetTOX-GFP (which expresses tetanus toxin, preventing neurotransmitter release and effectively silencing all PBN neurons, plus GFP) in mice that also received injections of AAV-hM3Dq in the PBN of Lepr Cre mice ( Figure 7A . As previously, CNO increased blood glucose concentrations in mice expressing hM3Dq in LepRb PAG neurons plus control virus in the PBN (Figure 7 , B and C). In contrast, the hyperglycemic effect of CNO was diminished in mice expressing hM3Dq in LepRb PAG neurons plus AAV-TetTOX-GFP in the PBN. Thus, PBN-mediated neurotransmission plays a crucial role in the control of blood glucose by LepRb PAG neurons. Thus, the withdrawal of leptin action from LepRb PAG cells enhances glucose mobilization and other autonomic responses to noxious stimuli (pain, hypercapnia) that signal acutely increased metabolic demand, consistent with a crucial role for these cells in the brain system that promotes adequate glucose mobilization and SNS activity when metabolic requirements increase acutely during negative energy balance ( Figure 7D ).
Discussion
We have identified a role for low leptin during negative energy balance in augmenting the autonomic response to noxious stimuli that signify acute unmet metabolic needs, thus ensuring that the drive to mobilize glucose is sufficient to overcome the additive effects of low SNS tone and depleted body energy stores ( Figure  1A ). Hence, this system can mitigate the detrimental effects of what would otherwise be diminished glucose mobilization during metabolic challenges in the face of the low SNS tone and depleted energy reserves that accompany negative energy balance.
Our findings also reveal the neural circuit that mediates this function ( Figure 7D ), beginning with LepRb PAG neurons -the largest group of LepRb neurons in the brain stem, whose function was previously unknown (6, 8) . Noxious stimuli (which indicate the need to mobilize glucose to support appropriate responses) decreased leptin action on LepRb PAG cells enhances glucose mobilization during noxious stimuli ( Figure 6G ). Importantly, however, measures of pain perception and sensitivity were not altered in LepRb PAG KO mice (Supplemental Figure 8) , indicating that leptin action via the PAG controls glucose mobilization during noxious stimuli, but does not alter the threshold for noxious stimulus perception. Furthermore, the breathing frequency of LepRb PAG KO mice was not different from that of controls in room air, but increased compared with control animals in the presence of 3% CO 2 ( Figure 6H) , consistent with the notion that decreased leptin action on LepRb PAG cells enhances the autonomic hyperventilatory response to hypercapnia.
Our tracing experiments (Figures 2 and 3) suggest that projections from LepRb PAG cells to the PBN could mediate the actions of these cells. To test this directly, we injected control AAV-GFP or Cre mice were treated with either CNO or vehicle, and respiratory frequency was monitored at baseline and during exposure to 3% CO 2 in a whole-body plethysmograph. Data are plotted as mean ± SEM; *P < 0.05. Data in panels B-E were analyzed by 2-way repeatedmeasures ANOVA with Fisher's LSD post hoc test. Data in panel F were analyzed using a 1-tailed t test.
activate LepRb PAG neurons, which project to the PBN→VMN circuit and promote SNS outflow and glucose mobilization. The withdrawal of leptin action from LepRb PAG cells enhances glucose mobilization in response to noxious stimuli, revealing a role for these cells in ensuring adequate glucose mobilization in response to acute demands when leptin levels are low due to negative energy balance. In addition to the obvious survival benefit conferred by this system in the wild, it may also complicate the analysis of glycemic control, especially by inexperienced researchers who inadvertently provoke noxious stimuli while measuring blood glucose in fasted or leptin-deficient animals.
Interestingly, the time course with which the hM3Dq-mediated activation of LepRb PAG neurons augments blood glucose is delayed relative to some acute sympathetic responses to noxious stimuli (such as those that increase heart rate and blood pressure). This finding may indicate that the negative energy balance-mediated augmentation of glucose mobilization in response to noxious stimuli operates via a different, more slowly acting system and thus with a delayed time course compared with these other parameters. This would suggest that LepRb PAG neurons and their circuits play more important roles in response to stimuli that develop over or last for many minutes, thus indicating the need for more sustained glucose mobilization (rather than mediating the immediate response to noxious stimuli that might be adequately met with an initial burst of SNS activation). Alternatively, activation of LepRb PAG neurons or the circuits they subserve might require other contextual cues to mediate the more immediate augmentation of blood glucose.
Since activating LepRb PAG neurons or ablating LepRb in these cells also augments the ventilatory response to hypercapnia (which signals high metabolic demand relative to ventilation), LepRb PAG cells presumably match ventilatory drive to the needs of acutely increased metabolic demand when leptin levels are low. These functions for LepRb PAG cells are consistent with the general role for the PAG in mediating sympathetic activation (23) (24) (25) and many autonomic responses to pain (12, 26) as well as the control of respiratory rate and the response to hypercapnia (19) (20) (21) (22) .
The PAG is a large nucleus, different regions of which play relatively distinct roles in autonomic and behavioral control. The ventral PAG receives projections primarily from the spinal cord and brain stem and mediates passive coping responses, such as freezing and decreasing blood pressure (25, 26) . In contrast, the dorsal PAG (especially the caudal dorsal PAG) receives projections from sensory processing centers and mediates active coping responses, such as increased SNS output and flight (23) (24) (25) (26) . The majority of the PAG LepRb cells lie within this caudal dorsal region of the PAG, which also contains the vast majority of noxious stimulus-activated LepRb neurons. Due to the size of the PAG, it is not possible to target the entire length and depth of this nucleus by injection; we focused on the caudal dorsal regions with our injections, using 2 injections per side (4 injections total per mouse) to sufficiently target the relevant populations of LepRb PAG neurons. The role of LepRb PAG cells in promoting SNS outflow, activity, glucose mobilization, and increased respiratory rate are consistent with the known output of this region. Since LepRb neurons in other areas of the PAG (and in adjoining structures, such as the DR) could mediate distinct processes, it will be interesting to define their functions as well.
This LepRb PAG →PBN→VMN circuit demonstrates multiple levels of specificity. Since it is engaged by the removal of leptin action, it is activated specifically during negative energy balance, when it is required to augment the drive to mobilize glucose. Also, it is activated only during times of acute need (i.e., it does not augment glucose mobilization in the absence of a noxious stimulus or another inciting event). Furthermore, the overall LepRb PAG →PBN→VMN system is specific for stressors that indicate an acute metabolic challenge (e.g., noxious stimuli, elevated CO 2 , or in the case of the PBN, glucoprivation); this system is not activated during restraint stress (8) The output of the LepRb PAG →PBN→VMN circuit is largely specific for the augmentation of SNS outflow: this brain stem circuit does not represent a mechanism by which leptin modulates food intake, body weight, or metabolism at baseline, since none of these parameters were altered in LepRb CCK KO PAG and LepRb PBN neurons overlap substantially makes teleological sense, since both circuits control similar physiologic end points (SNS outflow and glucose mobilization) and must therefore converge on the same output (the VMN in this case) to mediate their overlapping physiologic functions. This is not dissimilar to the convergence of DMH and arcuate nucleus (ARC) LepRb-expressing neurons on common pathways that control food intake and overall energy expenditure. While on the surface, it may seem redundant for leptin to act at multiple sites within a single circuit, leptin acts at least somewhat distinctly at these 2 sites; PAG LepRb neurons do not contribute to the CRR to hyperglycemia and are only involved in responding to noxious stimuli. Thus, leptin action on LepRb PAG cells does not alter the CRR to hypoglycemia, whereas PBN leptin action does.
The expression of LepRb in the PAG (in addition to the PBN) suggests that PBN LepRb on its own may not adequately augment SNS activation and glucose mobilization in response to noxious stimuli. If so, this could reflect the need for cell-autonomous leptin action to modulate the cellular response to the noxious input. While silencing all PBN neurons blocked the hyperglyce- (250 mg/kg, i.p.) , and (G) formalin (20 μl, hind paw) and blood glucose concentrations were followed. (H) Respiratory rate was measured at baseline and following exposure to 3% CO 2 . Data are plotted as mean ± SEM; *P < 0.05. Data in panels B-G were analyzed using 2-way repeated-measures ANOVA with Fisher's LSD post hoc test. Data in panel H were analyzed using a 1-tailed t test. neither does leptin alter that activity of LepRb PAG neurons in ex vivo slice preparations (data not shown). We previously observed that leptin inhibits LepRb PBN cells under low-glucose conditions (8), but we were unable to detect leptin-mediated inhibition of these cells in normal glucose, suggesting that a relevant activating stimulus might be required to observe the inhibitory effect of leptin on these cells. Hence, the effect of leptin on LepRb PAG cells might also be detectable only during activation of the neurons by other stimuli (e.g., by pain or hypercapnia). Unfortunately, it is not possible to stimulate ex vivo slice preparations with pain or hypercapnia, since the neurons that initially detect these stimuli lie remote to the LepRb PAG cells. Thus, leptin might inhibit LepRb PAG neurons, but technical issues prevent us from detecting this change in ex vivo slices. Since LepRb PAG neurons are largely glutamatergic (data not shown), the activation of these cells by leptin could also stimulate an inhibitory interneuron to mediate the observed effects. It is also possible that leptin does not directly or acutely alter the firing rate of LepRb PAG neurons, but rather mediates a transcriptional change that alters the magnitude of the response evoked by activating stimuli. Additionally, it is theoretically possible that the PAG could contain multiple subtypes of LepRb neurons.
Despite the power and utility of the genetic tools that we have employed to dissect the function of LepRb PAG neurons, it must be recognized that these manipulations are artificial and extreme; the level of activation, silencing, or degree of leptin insensitivity that these tools produce is unlikely to be recapitulated under physiologic circumstances. Nonetheless, the consistency of the Cre mice were injected with AAVhM3dq in the PAG and either a GFP-expressing control virus (n = 7) or AAV-TetTOX-GFP (n = 10) to constitutively express GFP or GFP plus TetTOX in the PBN, respectively. All mice were randomly assigned to receive vehicle control or CNO; mice received the other treatment the following week (B and C). Glycemic responses following vehicle injection were not different between groups and were thus combined into a single control group. (D) Our data demonstrate that PAG LepRb neurons act via the PBN to mobilize glucose and increase adrenal SNA when activated by noxious stimuli such as pain and hypercapnia. In the presence of sufficient energy stores, leptin inhibits these neurons to limit sympathetic activation and hyperglycemia to appropriate levels during the response to noxious stimuli. When energy stores are depleted, however, loss of leptin inhibition of PAG LepRb neurons augments sympathetic and glycemic responses to noxious stimuli to ensure a sufficient glucose mobilization in response to noxious stimuli, despite reduced overall sympathetic tone and the depletion of energy stores. Data are plotted as mean ± SEM; groups with different letters are significantly different. P < 0.05. Data in panel B were analyzed using 2-way repeated-measures ANOVA with Fisher's LSD post hoc test. Data in panel C were analyzed using 1-way ANOVA with Fisher's LSD post hoc test.
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30% sucrose for at least 1 day. Brains were cut into 30-μm sections on a freezing microtome in 4 series and stored in antifreeze solution (25% ethylene glycol, 25% glycerol). Sections were washed with PBS and then treated sequentially with 1% hydrogen peroxide/0.5% sodium hydroxide, 0.3% glycine, and 0.03% sodium dodecyl sulfate. Pretreatment was followed by an hour in blocking solution (PBS containing 0.1% Triton X-100, 3% normal donkey serum), then overnight incubation in blocking solution containing rabbit anti-c-Fos (sc-52, Santa Cruz Biotechnology Inc., 1:1000) and/or chicken anti-GFP (GFP-1020, Aves, 1:1000), rabbit anti-dsRed (632496, Living Colors, 1:1000), rabbit anti-pSTAT3 (91455, Cell Signaling Technology, 1:500), or rabbit anti-calcitonin gene-related peptide (anti-CGRP) (PC205L, Millipore, 1:1000) at room temperature. The next day, the sections were incubated with fluorescent secondary antibodies (Molecular Probes, 1:200) or with biotinylated secondary antibody (Jackson Immunoresearch, 1:200) followed by ABC amplification (Vector Laboratories, 1:500) and diaminobenzadine (Thermo Scientific) reaction. The sections treated with biotinylated secondary antibody were exposed to avidin/biotin complex solution followed by diaminobenzadine reaction. The sections were mounted onto slides coverslipped with Fluoromount-G (Southern Biotech). Images were collected on an Olympus Bx53 microscope, and the number of immunoreactive cells were counted using Adobe photoshop. The number of c-Fos-positive nuclei colocalizing with GFP-expressing cells were counted, along with total GFP-containing cells, and were expressed as a percentage of all GFP-expressing cells within the region of interest. Phenotypic studies. Body weight and food intake were monitored weekly in animals starting at 3 weeks after surgery. Glycemic measures, including glucose tolerance test (GTT) (2 g/kg body weight, i.p.), insulin tolerance test (ITT) (1.2 unit/kg body weight, Humulin, Eli Lilly, i.p.), 2DG (Sigma-Aldrich) challenge (250 or 500 mg/kg body weight, ip), and formalin challenge (20 μl; 5% formalin, intra-hind paw) were determined in 12-to 18-week-old animals by analyzing tail vein blood with a OneTouch Ultra 2 glucometer (Johnson & Johnson). For formalin challenge, mice were not included in the study unless there was visual inspection confirming inflammation of the hind paw to control for a missed injection. To measure leptin-induced pSTAT3, animals were fasted for 24 hours prior to leptin administration. For fasting modulation of hyperglycemic responses to intra-hind paw formalin injection, mice were fasted for 12 hours. For DREADD studies, CNO (Tocris Biosciences) was administered via i.p. injection at 0.3 mg/kg body weight.
Stereotaxic injections. Eight-to fourteen-week-old animals were anesthetized with 1.5%-2% isoflurane in preparation for craniotomy. The skull was exposed, bregma and lambda were leveled, a hole was drilled, and we injected the contents of a pulled pipette at the coordinates of our target for approximately 25 nl/min. For the PBN, 100 nl of virus was injected at anteroposterior (AP) -4.85, mediolateral (ML) ± 1.2, and dorsoventral (DV) -3.3. For the PAG, 100 nl of virus was injected at 4 separate coordinates per animal (AP: -4.9, ML: 0, DV: 0.7; AP: -4.8, ML: ± 0.6, DV: 0.95; AP: -4.7, ML: 0, DV: 0.8). For the VMN, 50 nl was injected at AP: -1.1, ML: ± 0.35, DV: -3.3. After 5 minutes, to allow the virus to diffuse into the brain, the pipette was raised slowly out of the hole in the skull, the hole in the skull was filled with bone wax, and the skin was closed with surgical sutures (Henry Schein). Analgesics were administered prophylactically to all mice to prevent postsurgical pain. The animals were allowed 4 weeks to recover from results produced by the various approaches undertaken suggests the veracity of our conclusions.
In addition to revealing the function of the largest population of LepRb neurons in the brain stem (LepRb PAG neurons), which had not, to our knowledge, previously been studied, our findings define a new component of the response to fasting and a new physiologic role for leptin: in addition to the hypothalamically mediated energy-sparing neuroendocrine response to starvation, low leptin augments the activation of a LepRb PAG →PBN→VMN circuit that ensures adequate SNS drive and glucose mobilization to meet the metabolic needs associated with noxious stimuli or hypoglycemia during negative energy balance. In the future, it will be important to identify other stimuli that act via this system to augment SNS outflow during negative energy balance as well as to define the detailed mechanisms by which this circuit mediates glucose mobilization.
Methods
Animals. All mice were provided with food and water ad libitum unless noted otherwise and kept in a temperature-controlled room on a 12-hour light/12-hour dark cycle. All experiments were carried out using approximately equal numbers of male and female mice. Animals were processed and studied in the order of their randomly assigned ear tags. Investigators were blinded to the genotype and/or treatment for all studies. All mice were genotyped via PCR across the potentially mutated region prior to study. C57BL/6 animals originated from Jackson Laboratories, but all other mice were bred within our colony.
Lepr
Cre/Cre mice were on a C57BL/6 background, as previously described (8, (30) (31) (32) Reagents. The AAV-map2c-dsRed was developed by cloning the coding sequences for the map2c-dsRed fusion protein (in reverse orientation) into the base Cre-inducible AAV vector, using SacI and NheI restriction sites. AAV-map2c-dsRed stocks were prepared at the University of North Carolina (UNC) Vector Core (Chapel Hill, North Carolina, USA). The AAV-Syn-GFP and AAV-TVA+G helper viruses were previously described (33, 34) ; viral stocks were prepared at the UNC Vector Core. The Rabies-ΔG-mCherry was as previously described (18, 34) and was generated at the University of Michigan Viral Vector Core with the support of the Molecular Genetics core of the Michigan Diabetes Research Center (University of Michigan). AAV-hM3dq, AAV-mCherry, AAV-GFP, and AAV-Cre were purchased from the UNC vector core. AAV-TetTox-GFP was from the Stanford University Viral Vector Core (Stanford, California, USA).
Perfusion and immunohistochemistry. Brains were collected and processed as previously described (8) . To reveal leptin-responsive neurons by pSTAT3, leptin was administered (5 mg/kg, i.p.) 2 hours prior to perfusion. For c-Fos studies, mice were exposed to a given stimulus 90 minutes prior to perfusion. After either stimulus exposure or leptin administration, mice were anesthetized with avertin prior to transcardial perfusion with PBS followed by 10% formalin. Brains were removed and placed into 10% formalin overnight, followed by jci.org Volume 127 Number 8 August 2017
was recorded (36) . As with the tail-flick test, 3 separate instances of this test were recorded and averaged for an individual data point. Respiratory measurement. Baseline ventilation and the ventilatory response to hypercapnia were measured in freely moving, conscious 14-to 18-week-old mice using a whole-body plethysmograph (Emka Technologies). Gas tanks of O 2 , N 2 , and CO 2 were connected to the plethysmograph and digitally controlled by the plethysmograph to deliver gas mixtures into each plethysmograph mouse chamber. Each mouse was placed inside the chamber for 20 minutes to acclimate. After acclimation, baseline ventilation was measured while the mice were exposed to room air (e.g., 21% O 2 , 79% N 2 , 0% CO 2 ). To determine the ventilatory response to hypercapnia, the CO 2 concentration inside the chamber was elevated to 3% for periods of 4 minutes, separated by 5-minute recovery periods in room air (similar to ref. 37) , while real-time breathing frequency was recorded. As CO 2 was increased, N 2 was decreased to allow O 2 levels to be stabilized at 21%. In total, mice remained in the plethysmograph for approximately an hour. All respiratory measures were recorded between 8 am and 1 pm. During recording, mice were continuously monitored by the investigator to ensure that they stayed awake (as the ventilation response is blunted by sleep; ref. 37) . If a mouse fell asleep, the investigator aroused the animal by gently tapping on the chamber.
Statistics. Statistical methods were not used to predetermine sample sizes, but our sample sizes are similar to those in previously published studies using similar approaches (8, 17, (37) (38) (39) . Sample sizes for groups that involved stereotaxic injection of specific populations of cells were 40% larger than for other groups to account for a 50%-60% bilateral hit rate. c-Fos data and activity data were analyzed by 1-tailed t test. Blood glucose data were analyzed by 2-way repeated-measures ANOVA with Fisher's least significant difference (LSD) post hoc test. Adrenal SNA data were analyzed by 1-tailed t test of 5-minute bins across the experiment. No data were removed unless the injection was a miss or the animal was sick or injured at the time of the experiment (loss of >10% body weight). Data that did not fall under a normal distribution or equal variance were log transformed, then reanalyzed. Significance was set at P ≤ 0.05. All data were analyzed using SigmaStat (Systat).
Study approval. The procedures included in this manuscript were approved by the appropriate Committees on the Use and Care of Animals at the University of Michigan and the University of Iowa.
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